• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·China·Healthcare·600055.SS
Share

Beijing Wandong Medical Technology Co.,Ltd. Stocks

CN¥ 10.28Last Updated 15.10.2026

Issuer Rating

4/7
Performance

Modest

Risk

Low

Recommendation

Hold

Market Cap

CN¥ 1.10B

CN¥ 10.28
Key Takeaways

Risk factor

Strong & resilient to price shocks

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very poor margins and returns

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Beijing Wandong Medical Technology Co., Ltd. focuses on the development, production, and sale of advanced medical diagnostic equipment. Their product lineup includes sophisticated MRI solutions, as well as a broad spectrum of radiological imaging systems. This range of radiological offerings features CT scanners, the CGO series, DR and DRF systems, digital mammography units, and mobile X-ray machines. The company, which was previously named China Resources Wandong Medical Equipment Co., Ltd., was founded in 1955 and maintains its headquarters in Beijing, China.

Company Valuation

Slightly overvalued
3/7

From both historical and forecast perspectives, the stock is slightly overpriced compared to similar stocks. Specifically, the stock is overvalued on EV/EBITDA, overprice

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

15.10.2026 22:40

CoreWeave's credit risk has reached a record high: markets estimate the probability of default at 60%

15.10.2026 22:30

Freedom Expects CrowdStrike Shares to Rise 28%. How Could the AI Boom Help the Company?

15.10.2026 21:52

Panic has gripped CoreWeave investors. What do analysts recommend doing with the stock?

15.10.2026 21:34

"Things are looking up": Nvidia's CEO saw no need to hedge against CoreWeave

15.10.2026 20:12

It's Time to Bet on Prozac: What Wall Street Is Saying About the Collapse of Data Center Operators

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026